FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to compounds of formulas 
I, 
II, 
III, 
IV, 
V, 
VIII or to their pharmaceutically acceptable salts, wherein: Z represents 
, 
or phenyl; D represents 
or 
; X represents N(R9), O, S, S(=O) or S(O)2; each Y independently represents O or S; G represents 
or 
; the other radical values are described in the patent claim. The invention also refers to pharmaceutical compositions based on the above compounds.
EFFECT: there are prepared new compounds and based compositions which can find application for treating malaria or eliminating or inhibiting the growth of Plasmodium species.
30 cl, 3 tbl, 23 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CFTR REGULATORS AND THEIR APPLICATION METHODS | 2016 |
|
RU2749834C2 |
| CFTR REGULATORS AND METHODS OF USING | 2016 |
|
RU2730855C2 |
| COMPOUNDS FOR USE IN TREATMENT OF MUCOSITIS | 2012 |
|
RU2606128C2 |
| CFTR REGULATORS AND METHODS FOR USE THEREOF | 2016 |
|
RU2742934C2 |
| METALLOPORPHYRIN TREATMENT OF NEUROLOGICAL DISEASES | 2012 |
|
RU2623207C2 |
| ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE | 2019 |
|
RU2797622C2 |
| COMPOUNDS FOR TREATING TRIPLE-NEGATIVE BREAST CANCER AND OVARIAN CANCER | 2019 |
|
RU2776897C2 |
| AMYLOID-BINDING AGENTS | 2010 |
|
RU2517174C2 |
| METHOD OF OBTAINING 5- HALOGENALKYL-4,5-DIHYDROISOXAZOLE DERIVATIVES | 2008 |
|
RU2536039C2 |
| COMPOSITIONS AND METHODS OF TREATING DISEASES AND CONDITIONS | 2015 |
|
RU2713886C2 |
